Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion - The New York Times
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS DRUGS SOCIETY Stock Photo -
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm to Close Plant in Israel After No Buyer Found
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
An Israeli worker of Teva Pharmaceutical Industries wears a working shirt and a pendant of the Star of David during a demonstration at the entrance to the facility in Neot Hovav, southern
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva settles shareholder lawsuit over generic drug | Business Insurance
Matko Bolanca, the new chief executive of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries, poses in his Zagreb office March 18, 2010. Pliva was Croatia's biggest drugs firm in the
Oklahoma Reaches $85 Million Settlement With Teva Pharmaceuticals Ahead of Trial
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva settles shareholder lawsuit over generic drug pricing for $420 million By Reuters
Israeli pharmaceutical giant Teva investigating bribery accusations in Romania | The Times of Israel
Teva stock plummets 18% after rough quarter in US generic drug market
Teva's deal with Allergan continues a massive year for pharma M&A — Quartz
Teva shares plunge after drugmaker misses revenue forecasts
Teva under police investigation in home market of Israel | Financial Times
A tourist poses for a photo with Teva Pharmaceutical Industries employees protesting outside Jerusalem's Old City December 24, 2017. REUTERS/Amir Cohen Stock Photo - Alamy
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva CEO: 'Content' With 2/3 Access of Payers for Migraine Drug Ajovy
Teva Pharmaceuticals - Wikiwand
